|
KMID : 1200020210450010115
|
|
Diabetes & Metabolism Journal
2021 Volume.45 No. 1 p.115 ~ p.119
|
|
|
Status of Diabetic Neuropathy in Korea: A National Health Insurance Service-National Sample Cohort Analysis (2006 to 2015)
|
|
Moon Seong-Su
Kim Chong-Hwa
Kang Seon-Mee
Kim Eun-Sook
Oh Tae-Jung
Yun Jae-Seung
Cho Ho-Chan
Kim Dae-Jung
Park Tae-Sun
|
|
|
Abstract
|
|
|
|
This report presents the status of diabetic neuropathy (DN) in Korea as determined using a National Health Insurance Service-National Sample Cohort (NHIS-NSC). Annual prevalences of DN were estimated by age and gender using descriptive statistics. Pharmacological treatments for DN were also analyzed. The annual prevalence of DN increased from 24.9% in 2006 to 26.6% in 2007, and thereafter, gradually subsided to 20.8% in 2015. In most cases, pharmacological treatments involved a single drug, which accounted for 91.6% of total prescriptions in 2015. The most commonly used drugs (in decreasing order) were thioctic acid, an anti-convulsive agent, or a tricyclic antidepressant. In conclusion, the prevalence of DN decreased over the 10-year study period. Thioctic acid monotherapy was usually prescribed for DN. To reduce the socio-economic burden of DN, more attention should be paid to the diagnosis of this condition and to the appropriate management of patients.
|
|
|
KEYWORD
|
|
|
Diabetes mellitus, Diabetic neuropathies, National health programs
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
   
|